Informations générales (source: ClinicalTrials.gov)
Comparative Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma : Correlation With Immunohistochemistry (HYPONECK)
Interventional
Phase 2
Centre Henri Becquerel (Voir sur ClinicalTrials)
mars 2019
mars 2022
29 juin 2024
Hypoxia imaging has not been studied extensively by combining PET and MRI data. Few
studies performed the double imaging and none associated anatomopathology with it . This
study will use a rigorous methodology through the production of PET/MRI images at the
same time by transferring the patient directly from PET to MRI. In addition, the
population, unlike other studies, will include preoperative patients with 24-hour surgery
for hypoxia imaging by obtaining additional data through specific immunohistochemical
analysis of hypoxia.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre Henri Becquerel - 76000 - Rouen - France | Sebastien Thureau, Md, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patient with squamous cells carcinoma of oropharynx
- Age Superior to 10 years old
- Male or Female
- measurable target according RECIST criteria
- Patient with squamous cells carcinoma of oropharynx
- Age Superior to 10 years old
- Male or Female
- measurable target according RECIST criteria
- -Other histologic cancer than squamous cells carcinoma of oropharynx
- No measurable target
- Presence of metastasis